Stock BFRI BIOFRONTERA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Biofrontera Inc.

Equities

BFRI

US09077D2099

Delayed Nasdaq
Other stock markets
 11:32:22 01/05/2024 pm IST 		5-day change 1st Jan Change
1.96 USD +6.54% Intraday chart for Biofrontera Inc. +18.10% -29.23%
18/03 Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024
15/03 Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Evolution of the average Target Price on Biofrontera Inc.

Price target over the last 5 years

History of analyst recommendation changes

7a5f8548853546a0239abfe5e063e9.HSvQ5_RKvnrYbFSyXIhcPDFYo9-3QwpW4L8V8UagLrg.c0edrKMHiB3hWjfiaM0PUAkVzp34LkBhp_tsx3PyHowrT5KyogzGPZ8fBQ~8665328ed5545bc38e884e9e3c841504

Analyst Recommendations on Biofrontera Inc.

Benchmark Adjusts Biofrontera's Price Target to $18 From $140, Keeps Buy Rating MT
Benchmark Adjusts Price Target on Biofrontera to $7 From $11, Reiterates Buy Rating MT
Benchmark Capital Starts Biofrontera at Buy With $11 Price Target MT
Roth Capital Starts Biofrontera at Buy With $20 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.84 USD
Average target price
16 USD
Spread / Average Target
+769.57%
High Price Target
25 USD
Spread / Highest target
+1,258.70%
Low Price Target
7 USD
Spread / Lowest Target
+280.43%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Biofrontera Inc.

Benchmark Company
Benchmark Capital
Roth Capital Partners

Ratings for Biofrontera Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BFRI Stock
  4. Consensus Biofrontera Inc.